(WDNews) – In a groundbreaking move, the FDA has approved FluMist, the first flu vaccine that can be administered by individuals or caregivers at home. FluMist, a nasal spray vaccine, is approved for people aged 2 to 49. This new option offers a more convenient way for families to get vaccinated, making flu prevention more accessible.
“Today’s approval of the first influenza vaccine for self- or caregiver-administration provides a new option for receiving a safe and effective seasonal influenza vaccine potentially with greater convenience, flexibility, and accessibility for individuals and families,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research.
FluMist, first approved in 2003, has been widely used in healthcare settings. With the new self-administration approval, eligible individuals can now order the vaccine online, receive it through the mail, and use it at home. However, children under 18 will still need a caregiver to administer the spray.
“This approval adds another option for vaccination against influenza disease and demonstrates the FDA’s commitment to advancing public health,” Marks added.
The FDA’s decision is expected to ease the vaccination process during flu season and help protect millions from the influenza virus.
